<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font24 { font-size : 24; } .font27 { font-size : 27; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">treatment </span>
   <span class="font27">psychiatric </span>
   <span class="font24">bipolar </span>
   <span class="font20">review </span>
   <span class="font19">{border-style </span>
   <span class="font18">disorders </span>
   <span class="font18">patients </span>
   <span class="font18">px;} </span>
   <span class="font18">#ffffff;} </span>
   <span class="font18">Clin </span>
   <span class="font17">disorder </span>
   <span class="font17">Psychiatry. </span>
   <span class="font17">depression </span>
   <span class="font17">evidence </span>
   <span class="font17">level </span>
   <span class="font16">systematic </span>
   <span class="font16">adjunctive </span>
   <span class="font16">clinical </span>
   <span class="font16">non-PMs </span>
   <span class="font15">depression. </span>
   <span class="font15">effects </span>
   <span class="font15">symptoms </span>
   <span class="font15">anxiety </span>
   <span class="font15">efficacy </span>
   <span class="font15">meta-analysis </span>
   <span class="font14">drugs </span>
   <span class="font14">propranolol </span>
   <span class="font14">results </span>
   <span class="font14">use </span>
   <span class="font14">acid </span>
   <span class="font14">depression, </span>
   <span class="font14">minocycline </span>
   <span class="font14">mood </span>
   <span class="font14">stress </span>
   <span class="font13">Alzheimer’s </span>
   <span class="font13">NSAIDs </span>
   <span class="font13">disease </span>
   <span class="font13">disorders. </span>
   <span class="font13">effect </span>
   <span class="font13">major </span>
   <span class="font13">neuropsychiatric </span>
   <span class="font13">prevention </span>
   <span class="font13">px; </span>
   <span class="font13">randomized </span>
   <span class="font13">receptor </span>
   <span class="font13">role </span>
   <span class="font13">studied </span>
   <span class="font13">third-line </span>
   <span class="font13">{font-family </span>
   <span class="font13">Disord. </span>
   <span class="font13">controlled </span>
   <span class="font13">data </span>
   <span class="font13">depression: </span>
   <span class="font13">disorders, </span>
   <span class="font13">disorders: </span>
   <span class="font13">font-size </span>
   <span class="font13">guidelines </span>
   <span class="font13">meta-analysis. </span>
   <span class="font13">physical </span>
   <span class="font13">post-traumatic </span>
   <span class="font13">recommended </span>
   <span class="font13">therapy </span>
   <span class="font13">treatments </span>
   <span class="font13">trial. </span>
   <span class="font12">ADHD </span>
   <span class="font12">NAC </span>
   <span class="font12">cardiovascular </span>
   <span class="font12">case </span>
   <span class="font12">diseases </span>
   <span class="font12">double; </span>
   <span class="font12">medicine </span>
   <span class="font12">new </span>
   <span class="font12">registered </span>
   <span class="font12">schizophrenia </span>
   <span class="font12">trials </span>
   <span class="font12">Alzheimer </span>
   <span class="font12">Ketamine </span>
   <span class="font12">Minocycline </span>
   <span class="font12">N-acetylcysteine </span>
   <span class="font12">NMDA </span>
   <span class="font12">Psychiatry </span>
   <span class="font12">Psychopharmacol. </span>
   <span class="font12">anti-inflammatory </span>
   <span class="font12">associated </span>
   <span class="font12">association </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">disease. </span>
   <span class="font12">diseases, </span>
   <span class="font12">disorder, </span>
   <span class="font12">double-blind, </span>
   <span class="font12">high-quality </span>
   <span class="font12">known </span>
   <span class="font12">long </span>
   <span class="font12">medications </span>
   <span class="font12">non-PM </span>
   <span class="font12">positive </span>
   <span class="font12">potential </span>
   <span class="font12">prescribed </span>
   <span class="font12">psychiatry </span>
   <span class="font12">randomized, </span>
   <span class="font12">rifampicin </span>
   <span class="font12">risk </span>
   <span class="font12">safety </span>
   <span class="font12">solid; </span>
   <span class="font12">study </span>
   <span class="font12">useful </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">AD. </span>
   <span class="font11">Clinical </span>
   <span class="font11">Clonidine </span>
   <span class="font11">Depression </span>
   <span class="font11">Dialogues </span>
   <span class="font11">FDA </span>
   <span class="font11">Geriatr </span>
   <span class="font11">High </span>
   <span class="font11">Med. </span>
   <span class="font11">Neurosci </span>
   <span class="font11">Neurosci. </span>
   <span class="font11">Pharmacol. </span>
   <span class="font11">Pramipexole </span>
   <span class="font11">Propranolol </span>
   <span class="font11">Unipolar </span>
   <span class="font11">acute </span>
   <span class="font11">agonist </span>
   <span class="font11">anxiety, </span>
   <span class="font11">available </span>
   <span class="font11">bold </span>
   <span class="font11">bumetanide </span>
   <span class="font11">calcium </span>
   <span class="font11">courier; </span>
   <span class="font11">depressive </span>
   <span class="font11">development </span>
   <span class="font11">disease: </span>
   <span class="font11">disorder. </span>
   <span class="font11">doxycycline </span>
   <span class="font11">drugs, </span>
   <span class="font11">early </span>
   <span class="font11">effective </span>
   <span class="font11">em; </span>
   <span class="font11">guidelines. </span>
   <span class="font11">influence </span>
   <span class="font11">like </span>
   <span class="font11">main </span>
   <span class="font11">management </span>
   <span class="font11">medication </span>
   <span class="font11">memory </span>
   <span class="font11">mental </span>
   <span class="font11">molecules </span>
   <span class="font11">negative </span>
   <span class="font11">non-psychotropic </span>
   <span class="font11">panic </span>
   <span class="font11">prevent </span>
   <span class="font11">pt;} </span>
   <span class="font11">receiving </span>
   <span class="font11">recent </span>
   <span class="font11">reduce </span>
   <span class="font11">review. </span>
   <span class="font11">schizophrenia, </span>
   <span class="font11">schizophrenia. </span>
   <span class="font11">spectrum </span>
   <span class="font11">studies </span>
   <span class="font11">study. </span>
   <span class="font11">symptoms. </span>
   <span class="font11">treat </span>
   <span class="font11">treating </span>
   <span class="font11">treatment-resistant </span>
   <span class="font11">trials. </span>
   <span class="font11">used </span>
   <span class="font11">β-blockers </span>
  </p>
 </body>
</html>
